INTERNATIONAL PATENT: INSTITUT CURIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, EGLE THERAPEUTICS FILES APPLICATION FOR "T CELL BIOMARKERS OF RESPONSE TO CANCER THERAPY"

GENEVA, Dec. 1 -- INSTITUT CURIE (26 rue d'Ulm75005 Paris), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101 rue de Tolbiac75013 PARIS), EGLE THERAPEUTICS (5 rue Gardenat Lapostol92150 SURESNES) filed a patent application (PCT/EP2025/064196) for "T CELL BIOMARKERS OF RESPONSE TO CANCER THERAPY" on May 22, 2025. With publication no. WO/2025/242829, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PIAGGIO, Eliane (c/o Institut Curie,26 Rue d'Ulm75248 Paris Cedex 05)

Abstract: The present invention provides a m...